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U

pon maturation, dendritic cells (DCs) change their functions from Ag sampling to Ag presentation, in a process involving massive alterations in their morphology and motility. The actin cytoskeleton plays key roles in
multiple aspects of DC function (1–5). For example, Ag presentation by mature DCs depends on the integrity of the actin
cytoskeleton (5). Rac1/2, a small G protein that is responsible for
ruffling movements, has been shown to be essential for the interaction of DCs with T cells (1). Wiskott-Aldrich Syndrome
protein, a molecule that controls Arp2/3-dependent actin polymerization, is required for the formation of the immunological
synapse (2, 6). Although there is abundant evidence that alterations in actin dynamics are important for maturation-associated
changes in DCs, it is not clear which actin regulatory proteins
induce the profound alterations in morphology and motility observed upon DC maturation. Rac and Cdc42, which control the
assembly of membrane ruffling and filopodia, respectively (7), are
unlikely to play major roles in these alterations. Rac activity
appears to be either unchanged or increased minimally upon
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maturation (8, 9), whereas Cdc42 activity is decreased upon
maturation (9).
In addition to the profound alterations in morphology and
motility, DCs show reduced adhesion to the substrate upon maturation, as evidenced by the loss of podosomes, specialized
structures for cell-matrix adhesion (4, 10–12). Podosomes consist
of an actin core surrounded by a characteristic ring structure
containing adhesion molecules, including vinculin, talin, paxilin,
and integrin (13, 14). DCs transiently lose podosomes at ∼20 min
after activation with LPS, then recover podosomes by 2 h. Later,
they permanently lose podosomes at ∼5–7 h after activation,
concomitant with the generation of characteristic veil-like membrane protrusions (4, 10, 11). Although the first and transient loss
of podosomes is controlled via pathways involving PGE2, RhoA,
and rho-kinase (10, 15), as well as ADAM17 (12), it is not clear
what causes the second and permanent loss of podosomes in
mature DCs.
Fascin1, an actin-bundling protein (see for review Ref. 16),
is specifically induced to a great extent upon DC maturation,
whereas it is not detectable in immature DCs (17–20). Other blood
cells such as primary macrophages and T cells do not express or
induce fascin1. The induction of fascin1 in DCs suggests a specific
role for fascin1 in DC maturation. Fascin1 has been suggested
to be critical for assembly of filopodia or membrane protrusions.
Fascin1 is localized to filopodia (21–25), and fascin1 overexpression induces membrane protrusions and increases cell motility
of epithelial cells and colon carcinomas (26–28). Conversely,
fascin1 knockdown has been reported to block assembly of filopodia in cultured mammalian cells (27–29). In bone marrow–derived DCs, fascin1 depletion by antisense treatment resulted in the
inhibition of both dendrite formation and T cell activation (19, 20,
30). However, little is known about what roles fascin1 plays in
motility and cytoskeletal reorganization associated with DC maturation.
To determine the physiological function of fascin1 in DC
maturation, we generated fascin1 knockout (KO) mice (31). Fascin1 KO mice provide an excellent experimental system, allowing
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Dendritic cells (DCs) play central roles in innate and adaptive immunity. Upon maturation, DCs assemble numerous veil-like membrane protrusions, disassemble podosomes, and travel from the peripheral tissues to lymph nodes to present Ags to T cells. These
alterations in morphology and motility are closely linked to the primary function of DCs, Ag presentation. However, it is unclear how
and what cytoskeletal proteins control maturation-associated alterations, in particular, the change in cell migration. Fascin1, an
actin-bundling protein, is specifically and greatly induced upon maturation, suggesting a unique role for fascin1 in mature DCs. To
determine the physiological roles of fascin1, we characterized bone marrow-derived, mature DCs from fascin1 knockout mice. We
found that fascin1 is critical for cell migration: fascin1-null DCs exhibit severely decreased membrane protrusive activity. Importantly, fascin1-null DCs have lower chemotactic activity toward CCL19 (a chemokine for mature DCs) in vitro, and in vivo, Langerhans cells show reduced emigration into draining lymph nodes. Morphologically, fascin1-null mature DCs are flatter and fail
to disassemble podosomes, a specialized structure for cell-matrix adhesion. Expression of exogenous fascin1 in fascin1-null
DCs rescues the defects in membrane protrusive activity, as well as in podosome disassembly. These results indicate that fascin1
positively regulates migration of mature DCs into lymph nodes, most likely by increasing dynamics of membrane protrusions, as
well as by disassembling podosomes. The Journal of Immunology, 2011, 186: 2850–2859.
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us to analyze fascin function in DCs with little experimental
manipulation. In addition, fascin1 KO mice provide fascin1-null
phenotypes that are complete and uniform, unlike antisense or
small interfering RNA approaches that tend to be partial and
variable. Our results indicate that fascin1 profoundly alters DC
cytoskeletal organization and plays critical roles in migration of
mature DCs into lymph nodes for Ag presentation.

phalloidin, and DAPI. Because the expression of CD86 is well correlated
with that of fascin1 (see FACS analyses shown in Fig. 1A), CD86high DCs
were chosen to compare differences in thickness, area, and circularity
between fascin1-expressing wild-type and fascin1-null DCs. Orthogonal
images created by SoftWoRx were used for measurement of thickness.
Areas were measured with xy images of DCs at the ventral focal plane, and
circularities were measured with Z-projected images. Both areas and circularities were measured using ImageJ software.

Materials and Methods

Live cell imaging, kymography, microinjection, and
transfection

Reagents, Abs, and fascin1-deficient mice

Preparation of bone marrow DCs
Preparation of mouse bone marrow DCs was according to the method
described in Inaba et al. (32), with slight modification. Briefly, single-cell
suspension was prepared from bone marrow of femurs and tibias, and
plated on 65-mm dishes in DMEM containing 10% FCS and 10 ng/ml
GM-CSF for 7–10 d. Nonadherent cells were collected and DCs were
purified by centrifugation over a 13.7% (w/v) metrizamide discontinuous
gradient. More than 85% of cells collected at the interface of the gradient
were positive for CD11c. Cells were matured by overnight culture in the
presence of 100 ng/ml LPS (Sigma-Aldrich).

FACS analyses
Mature DCs were fixed with methanol or formalin, and stained with FITClabeled anti-DC markers including CD86, CD11c, and MHC-II. For double
labeling, methanol-fixed cells were blocked with a rat anti-mouse CD16/
CD32 Ab (mouse Fc block; BD Pharmingen) and incubated with the
mouse anti-fascin1 Ab (clone 55k-2) together with the FITC-labeled CD86
Ab, and then the fascin Ab was labeled with a R-PE–labeled goat antimouse IgG. Flow cytometry was performed with a Coulter Cytomics
FC500 flow cytometer.

Immunofluorescent microscopy and measurements of thickness,
area, and circularity
For staining with Abs against CD11c, CD86, MHC-II, and vinculin, as well
as for staining with rhodamine phalloidin (Molecular Probes, Eugene, OR),
DCs were fixed with 3.7% formaldehyde and permeabilized with 0.2%
Triton X-100 or 100% acetone. Absolute methanol fixation at 220˚C was
used for double labeling with the anti-fascin1 mouse mAb (clone 55k-2)
and the anti-CD86 Ab, and for double staining with anti-fascin1 and
anti–a-actinin Abs. Images were taken as Z-stacks (0.2 mm spacing) with
a DeltaVision Image Restoration Microscope system (Applied Precision,
Issaquah, WA), deconvolved either with the softWoRx software (Applied
Precision) or the Huygens software (Scientific Volume Imaging, Hilversum, The Netherlands). Projected images were generated with SoftWoRx
or ImageJ (http://rsb.info.nih.gov/ij/). In some experiments, images were
taken on a Nikon TE300 microscope with a 360 objective lens (NA 1.4).
Exposure times for imaging and settings for deconvolution were constant
for all samples to be compared within any given experiment. For presentation, image contrast and brightness were adjusted with Photoshop
(Adobe, San Jose, CA).
For measurements of thickness, area, and circularity, wild-type and
fascin1 KO DCs were labeled with the FITC-labeled CD86 Ab, rhodamine

For phase-contrast, live cell imaging, DCs were placed at 37˚C in a temperature-controlled incubator (MS200D; Narishige) and observed under
a Nikon microscope (TE300) with a 340 Plan Fluor phase-contrast (NA
0.60) objective lens. Time-lapse images were taken every 10 s for 20–30
min by a CCD camera (CoolSnap-fx; Roper Scientific) with IPLab image
analysis software (Scanalytics). Two to three kymographs were generated
for each cell with randomly chosen, one-pixel lines using ImageJ (National
Institutes of Health) with the Kymograph plug-in (written by J. Rietdorf
and A. Seitz, European Molecular Biology Laboratory). Kymographs were
then analyzed using ImageJ to determine rates of membrane protrusions
and retractions.
Microinjection of GFP fascin1 into differentiated THP-1 (human acute
monocytic leukemia cell line) cells was performed as follows: cells were
first differentiated into macrophages by the treatment of 200 nM 2-Otetradecanoylphorbol-13-acetate for overnight, as described (33). Microinjection was performed, as described previously (26), using GFP fascin1
at a needle concentration of 9 mg/ml. As a control, FITC-labeled BSA was
injected. After 1-h incubation, cells were fixed with formaldehyde, permeabilized with acetone, and counterstained with rhodamine-labeled
phalloidin or the anti-vinculin Ab to determine effects on podosome assembly. To estimate levels of fascin1 in injected cells, injected cells were
stained with the fascin1 Ab, and fluorescent intensities were compared
with those of uninjected cells and fascin1-expressing DCs. It was found
that injection increased the fascin1 level 5–10 times over the level of
endogenous fascin1 in THP-1 cells, the level of which is comparable to
that found in wild-type DCs.
Mature or immature DCs were transfected with a human GFP fascin1
fusion construct (26) using an Amaxa Nucleofector II, according to the
manufacturer’s instructions.

In vitro assay for chemotaxis
Chemotaxis of mature DCs was assayed in triplicate using a modified
Boyden chamber assay. CCL19 (MIP3b), a chemokine for mature DCs,
was added in bottom wells at the concentration of 0.6 mg/ml. Mature wildtype and fascin1 KO DCs (2 3 105 cells) were placed on top wells of
a collagen-coated Boyden chamber with 3-mm hole (Corning, Lowell,
MA). After 24-h incubation, cells transmigrated into the bottom chamber
were counted.

Preparation of epidermal sheets and assay for DC migration
into lymph nodes
Epidermal sheets before and after stimulation by FITC painting were
prepared essentially as described (34). Briefly, the dorsal surfaces of both
ears of wild-type and fascin1 KO mice were painted with 25 ml 1% FITC
in acetone/dibutylphthalate (1:1). After 24 h, epidermal sheets were isolated from dorsal halves of the ears and stained with anti–MHC-II Ab,
followed by Cy3-labeled donkey anti-rat Ab. Fifteen to 20 randomly selected fields were photographed with a Nikon TE300 with a 320 objective,
and the number of Langerhans cells per field (area, 149,000 mm2) was
counted.
Langerhans cells migrated into draining lymph nodes were prepared
essentially as described (35, 36). Briefly, mice were painted with the FITC
solution, as described above, except that both dorsal and ventral sides of
ears were painted with 15 ml solution (total 30 ml per one ear). After 24 h,
draining lymph nodes (auricular) were excised and cell suspension was
prepared through cell strainers (Falcon, 70 mm). DCs were then enriched
on metrizamide discontinuous gradients, as described above, and cytospun
onto coverslips. FITC-bearing DCs were identified and counted by fluorescence and phase-contrast microscopy, and Langerhans cell migration
was expressed as numbers of FITC-bearing DCs per lymph node.

Scanning electron microscopy
DCs grown on coverslips were fixed with 2% glutaraldehyde in 0.1 M
sodium cacodylate (pH 7.3) for 20 min at room temperature, and dehydrated
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The following Abs were used: FITC-conjugated hamster anti-mouse CD11c
mAb (BD Biosciences, San Diego, CA); FITC-conjugated rat anti-mouse
CD86 (B7-2) mAb; FITC-conjugated rat anti-mouse I-A/I-E (MHC-II)
mAb (BD Biosciences); mouse anti-vinculin mAb (Sigma-Aldrich, St.
Louis MO); rabbit anti–a-actinin Ab (25); mouse anti-fascin mouse mAb
(55k-2) (25); and chick anti-fascin Ab (generated by Aves Laboratories
[Tigard, OR], using recombinant human fascin1 as an Ag). GM-CSF and
CCL19 (MIP3b) were purchased from Invitrogen (Camarillo, CA).
Fascin1 KO heterozygous mice were generated by Lexicon Pharmaceuticals (Woodlands, TX) from an embryonic stem cell line (OST124903;
Lexicon’s OmniBank library of gene KO embryonic stem cell clones), and
backcrossed with C57BL/6 female mice for .16 generations (31). Both
RT-PCR and Western blot analyses revealed that the loss of fascin1 is not
compensated with the expression of the fascin1 paralogues (such as retina
fascin2 and testis fascin3) (31). For each experiment with homozygous
mice, their wild-type littermates were used as a control. All experimental
procedures and protocols for mice are approved by the Animal Care and
Facilities Committee at Rutgers. Mice were housed in an American Association for the Accreditation of Laboratory Animal Care-accredited
animal facility at Rutgers.
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by submerging graded ethanol solutions. After critical point drying and
platinum coating, images were taken with an Amray 1930I scanning microscope.

Statistical analysis
Statistical analyses were performed using Student t test (http://www.
physics.csbsju.edu/stats/t-test.html).

Results
Fascin1 deficiency does not alter expression of DC maturation
markers or other actin-binding proteins

Fascin1 is present in the cortex of membrane protrusions
We found that fascin1 was also localized at the cortex of veil-like
membranes (a more prominent structure than filopodia in mature
DCs) of mature wild-type DCs. Fig. 1D shows wild-type and
fascin1 KO DCs double labeled with phalloidin and anti-fascin1
Ab and imaged at two different focal planes (the ventral surface
and a middle). In wild-type DCs expressing high levels of fascin1,
both fascin1 and F-actin were colocalized at the cortex of veil-like
protrusions (arrowheads in Fig. 1Da–f). In contrast, fascin1 KO
DCs were more spread and showed many fewer veil-like protrusions either at the ventral surface or at the middle focal plane.
In addition, fascin1 KO DCs frequently showed a cluster of many
prominent actin dots at the ventral surface, which were reminiscent of podosomes (arrow in Fig. 1Dh). In contrast, most wildtype DCs did not exhibit such large and clustered dots. As described later, vinculin labeling revealed that these dots observed in
fascin1 KO DCs indeed represent podosomes (see Fig. 2).

Fascin1 is essential for dynamics of membrane protrusions
The presence of fascin1 in the cortex of membrane protrusions
(Fig. 1D) prompted us to examine whether the dynamics of membrane protrusions are altered by fascin1 deficiency. To this end, we
imaged live DCs plated on glass coverslips using phase-contrast
microscopy (Supplemental Videos 1, 2 for wild-type DCs, Supplemental Videos 3–5 for fascin1-deficient DCs). Fig. 3A–C illustrates representative still images of wild-type (A, corresponds to
Supplemental Video 1) and fascin1-null (B and C, corresponds to
Supplemental Videos 3, 4, respectively) DCs, respectively. Fig. 3B
represents the majority of fascin1-null DCs, whereas Fig. 3C
represents a minor fraction (,20%) of fascin1-null DCs. These
images clearly demonstrate that membrane activity of wild-type
DCs is much more vigorous than that in fascin-null DCs. Kymograph analyses (Fig. 3D–F) confirm that fascin1-null DCs (Fig.
3E, 3F) displayed greatly diminished dynamics compared with
wild-type DCs (Fig. 3D). Box plot analyses of protrusion (Fig.
3G) and retraction (Fig. 3H) rates generated from kymographs
(representing seven different live cell imaging experiments) revealed that the median value of the protrusion rate for wild-type
DCs (0.11 mm/s, n = 83) was 2.1 times higher than that of fascin1deficient DCs (0.053 mm/s, n = 85), and the retraction rate in wildtype DCs (0.10 mm/s, n = 84) was 4 times higher than that of
fascin1-deficient DCs (0.025 mm/s, n = 87).
To determine whether fascin1 is responsible for the dynamic
membrane movements, we re-expressed GFP fascin1 in fascin1 KO
DCs, and tested whether fascin1 was able to rescue the poor dynamics of membrane protrusions. Phase-contrast, time-lapse microscopy was performed with fascin1 KO DCs expressing GFP
alone (control, see Supplemental Video 6) or GFP fascin1 (Supplemental Video 7). As shown in both still images (Fig. 3I, 3J) and
kymographs (Fig. 3K, 3L), DCs expressing GFP fascin1 (Fig. 3J,
3L) exhibited much greater membrane protrusion dynamics than
did DCs expressing control GFP (Fig. 3I, 3K). Box plot analyses
(Fig. 3M, 3N) revealed a significant difference in both protrusion
and retraction rates (p , 0.0001): the median protrusion and retraction rates for DCs expressing GFP fascin1 were 0.18 mm/s (n =
103) and 0.13 mm/s (n = 98), respectively, whereas those of DCs
expressing GFP were 0.058 mm/s (n = 74) and 0.043 mm/s (n =
50), respectively. Thus, the protrusion/retraction rates of GFP
fascin1-expressing DCs were comparable to those of wild-type
DCs, whereas those for GFP-expressing DCs were similar to
those of fascin1-deficient DCs. These results indicate that fascin1
induction upon maturation is responsible for the vigorous dynamic
membrane movements of mature DCs.
Fascin1 is important for in vitro chemotaxis of mature DCs
toward CCL19
The lower membrane protrusive activity of fascin1-deficient,
mature DCs would be predicted to impair their migratory efficiency. To test this idea, we examined, using a modified Boyden
chamber (3-mm holes with collagen coating), whether fascin1
deficiency affects chemotaxis of mature DCs toward CCL19
(MIP3b). As Fig. 4A shows, fascin1 deficiency reduced chemotaxis by 42% (p = 0.0095).
Fascin1-deficient mice show reduced migration of Langerhans
cells
Consistent with the impaired chemotaxis of fascin1 KO DCs toward CCL19 in vitro, we found that Langerhans cells of fascin1 KO
mice showed reduced migration into lymph nodes. Twenty-four
hours after painting of dorsal sides of both ears with an allergen
of FITC, epidermal cell sheets were prepared and stained with
a MHC-II Ab. Fig. 4B shows representative immunofluorescence
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As a first step toward characterization of fascin1-null DCs, FACS
analyses were performed to determine whether fascin1 deficiency
affects expression of DC markers, including CD11c, CD86, and
MHC-II, when bone marrow-derived DCs were activated by 100
ng/ml LPS. As shown in Fig. 1A, surface expression of the DC
marker CD11c (Fig. 1Aa) and the maturation markers MHC-II and
CD86 (Fig. 1Ab, 1Ac) were similar between wild-type and fascinnull, mature DCs, indicating that fascin1-null DCs are able
to mature in terms of the expression of maturation markers. As
expected, fascin1 was expressed only in wild-type, but not fascin1
KO DCs (Fig. 1Ad, 1Af). As shown in Fig. 1Ae, double labeling
with anti-fascin1 and anti-CD86 Abs revealed a strong correlation
between fascin1 and CD86 expression in wild-type DCs. Before
LPS activation, both wild-type and fascin1-null DCs expressed
similar levels of CD11c, whereas neither cell type expressed appreciable levels of CD86 (data not shown). These results are
consistent with previous reports that fascin1 depletion by antisense treatments did not alter expression of DC maturation
markers (19, 20, 30).
Western blot analyses confirmed that fascin1 is induced upon
maturation of wild-type DCs (Fig. 1B, lane 2), whereas it is absent
in immature, wild-type DCs (lane 1), as well as immature and
mature fascin1 KO DCs (lanes 3 and 4, respectively). We examined whether fascin1 deficiency alters expression of other actinbundling proteins, including fimbrin and a-actinin. Fimbrin levels
are largely unaltered between wild-type and fascin1 KO DCs,
regardless of maturation. a-Actinin was barely detectable in DCs,
and its levels appear unchanged. The levels of vinculin, however,
are slightly increased in fascin1 KO DCs.
Fig. 1C shows immunofluorescence localization of fascin1 and
CD86 of wild-type as well as fascin1 KO DCs. As expected,
fascin1 KO DCs showed no fascin1 staining, whereas CD86staining intensities were similar between wild-type and fascin1
KO DCs, confirming the FACS analyses. As previously reported
(17, 25, 37, 38), fascin1 was localized at filopodia-like structures.

FASCIN1 IN DC MATURATION
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images of wild and KO epidermal sheets. Without allergen, both
wild-type and KO sheets showed a similar Langerhans cell distribution. After stimulation with the allergen, Langerhans cells
from wild-type mice clearly exhibited decreased cell density when
compared with KO. Quantitative data (Fig. 4C) indicate that the
mean density of wild-type Langerhans cells after stimulation was
about half of that of fascin1 KO (p , 0.001), whereas the density
of Langerhans cells before stimulation was statistically similar
between wild-type and fascin1 KO mice.
To confirm that the above difference in Langerhans cell density
is indeed due to migration of Langerhans cells into lymph nodes,
we measured the number of FITC-bearing DCs in draining lymph
nodes following stimulation by FITC painting for 24 h. As Fig.
4D shows, there were over twice as many FITC-bearing DCs
per lymph node in wild-type mice as in fascin1-null mice
(p = 0.0059). Taken together, these results show that Langerhans
cell migration is impaired in fascin1 KO mice, and support our
hypothesis that fascin1 plays a critical role in DC migration into
lymph nodes by promoting podosome disassembly and increasing
dynamics of membrane protrusions.
Fascin1-deficient DCs are more spread and thinner with fewer
membrane protrusions
Fascin1-deficient, mature DCs are morphologically very different
from their wild-type counterparts. Fig. 5A shows scanning electron

microscopy of wild-type and fascin1-null mature DCs. Fascin1deficient DCs were much thinner and more spread with fewer and
smaller dorsal ruffles than wild-type DCs. To quantitatively assess
these shape changes, cells were labeled with rhodamine phalloidin
and anti-CD86 Ab, and analyzed by immunofluorescence microscopy, using serial Z-section imaging (0.2 mm spacing) and
three-dimensional rendering. Because the expression of CD86
correlates with that of fascin1 (Fig. 1Ae), CD86high DCs were
chosen for morphological analysis. Fig. 5B shows representative
images of wild-type and KO CD86high DCs stained with phalloidin. Orthogonal images in both xz and yz planes clearly showed
that fascin1-deficient DCs were thinner than wild type. Statistical
analyses using box plots (Fig. 5C) revealed a significant difference
in thickness (p , 0.0001). The median thickness of fascin1deficient DCs (n = 126) was 7.4 mm, whereas that of wild type
(n = 196) was 10.7 mm. The difference in the thickness became
even more prominent when DCs were centrifuged at 110 3 g for
4 min; fascin1-deficient DCs were greatly flattened, with a median
thickness of 3.6 mm (n = 55), whereas wild-type DCs were more
resistant with a median thickness of 6.9 mm (n = 45). These results
suggest that DC stiffness may be impaired in fascin1-deficient DCs.
To determine how fascin1 deficiency affects cell spreading, we
made area measurements of xy images on the ventral surface. As
the box plot of Fig. 5D shows, fascin1-deficient DCs are 40%
more spread: the median area covered by fascin1-deficient DCs
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FIGURE 1. Characterization of wild-type and fascin1-null DCs. A, FACS analyses of wild-type (red
line) and fascin1-deficient (blue line), mature DCs.
Black lines, controls without Ab labeling. a, CD11c; b,
MHC-II; c, CD86; d, fascin1. e and f, FACS analyses
of wild-type (e) and KO (f) DCs double labeled with
CD86 and fascin1 Abs. B, Western blot analyses. Immature (IM; lanes 1 and 3) and mature (M; lanes 2 and
4) DCs prepared from wild-type (lanes 1 and 2) and
fascin1 KO (lanes 3 and 4) mice were analyzed with
the indicated Abs. C, Immunofluorescent localization
of fascin1 and CD86 in mature wild-type (a–c) and
fascin1 KO (d–f) DCs. Mature DCs were double labeled with anti-CD86 (a, d; green) and mouse antifascin1 (b, e; red) Abs. c and f, Merged images. Scale
bar, 10 mm. D, Localization of fascin1 and F-actin in
wild-type (a–f) and fascin1 KO (g–l) DCs. Cells were
labeled with chick anti-fascin1 (a, d, g, j; green) and
rhodamine phalloidin (b, e, h, k; red). Images were
taken at the ventral surface (a–c, g–i), as well as at the
middle (d–f, j–l) of the same cells. c, f, i, and l, Merged
images. Arrowheads indicate colocalization of fascin1
and F-actin at the cortex of veil-like protrusions. Scale
bar, 10 mm.
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was 290 mm2 (n = 95), whereas that of wild-type DCs was 205
mm2 (n = 121), with a statistical significance (p = 0.0032). As
wild-type DCs were 30% thicker than fascin1-deficient DCs, these
measurements suggest that both types of DCs have roughly equal
cell volumes.
The size and shape of protrusions varied widely, making simple
measurements of the number and length of protrusions inappropriate for quantitative analyses. We thus measured circularity
([4p] 3 [area]/[perimeter]2) of projected images generated from
Z-section images, because more protrusions result in higher deviation from circularity (the value for a complete circle is 1). Box
plot analyses (Fig. 5E) showed that fascin1 deficiency increased
the median values of circularity from 0.39 (n = 112) to 0.51 (n =
120) with the statistical significance of p , 0.0001, confirming
that fascin1 KO DCs have fewer protrusions. The finding that
fascin1-null DCs show reduced numbers of protrusions is consistent with previous studies demonstrating the role of fascin1 in
generating membrane protrusions in other cell types (16, 26, 29,
39, 40).
Fascin1-deficient DCs fail to disassemble podosomes upon
maturation
Podosomes are disassembled in mature DCs (4, 10, 11). The
images at the ventral surface of fascin1 KO DCs (Figs. 1Dh, 5Bb)
showed many more podosome-like F-actin dots than in wild-type
DCs, suggesting a difference in podosome dynamics. We found
that this is the case. Fig. 2A shows immunofluorescence images of

vinculin-labeled (red) immature and mature DCs from wild-type
and fascin KO mice. In each case, DCs were identified by counterstaining with CD11c (green). Immature DCs from both wildtype and fascin1 KO DCs assembled podosomes to a similar extent. This result is consistent with the observation that fascin1
expression is minimal in immature DCs. As reported (4, 11),
podosomes disappeared in most mature wild-type DCs. In sharp
contrast, mature fascin1 KO DCs retained podosomes. We performed quantitative analyses of podosome number in CD11cpositive DCs by setting a criterion that DCs with a cluster of
more than five podosomes (defined as vinculin-positive ring-like
structures) were judged as podosome positive. Such measurements
(Fig. 2C) revealed that, whereas the percentage of wild-type DCs
with podosomes decreased from 65 (n = 117) to 22% (n = 166)
upon maturation, the percentage of podosome-positive, fascin1deficient DCs was unchanged by maturation (61% for immature,
n = 158 and 59% for mature DCs, n = 111).
We found that the loss of podosomes is highly correlated with
the extent of fascin1 expression. As shown in our FACS analyses
(Fig. 1Ad, 1Ae), mature wild-type DCs can be grouped into two
populations, one (∼40–50% of mature wild-type DCs) showing
two orders of magnitude higher expression of fascin1 than the
other. We examined the presence of podosomes in such fascin1high
DCs by double staining with the anti-fascin1 and anti-vinculin Abs
(Fig. 2B). We found that virtually all DCs expressing the higher
level of fascin 1 (n = 100) had no podosomes (pink bar, Fig. 2C),
suggesting an important role for fascin1 in podosome loss. This
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FIGURE 2. Fascin1 expression and actin-bundling activity are critical for podosome disassembly of mature DCs. A, Immunofluorescence of immature (a,
b) and mature (c, d) DCs from wild-type (a, c) and fascin1-null (b, d) mice labeled with anti-vinculin (red) and anti-CD11c (green) Abs. Arrows,
podosomes with the characteristic ring structure; arrowheads, focal adhesions. Scale bar, 15 mm. B, Mature fascin1high DCs (arrow) show no podosome
assembly. Scale bar, 10 mm. C, Statistical analyses of podosome assembly. CD11c-positive immature (blue bar) and mature (red) DCs with at least five
vinculin-positive podosomes were judged as DCs with podosomes. Wild-type, mature DCs with very high fascin1 expression (.10 times higher than
background; pink bar) were also examined for podosome assembly. D, Effects of forced expression of GFP control (a–c), GFP wild-type fascin1 (d–f), GFP
A-fascin1 (g–i), and GFP D-fascin1 (j–l) on podosome assembly. Fascin1-null DCs were transfected with GFP control (a–c), as well as with wild-type and
fascin1 mutants, and stained with anti-vinculin Ab (red; b, e, h, k). GFP signal (green; a, d, g, j); merged images (c, f, i, l). Arrowheads in j–l show
podosomes. Scale bar, 10 mm. E, Statistical analyses of podosome loss. Podosomes were counted in DCs exogenously expressing control GFP, GFP Wfascin1, GFP A-fascin, or GFP D-fascin, and cells were categorized as having less than four podosomes or more than five podosomes.
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notion is consistent with the observation that the timing of fascin1
induction (∼7 h after LPS treatment) roughly corresponds to the
time when mature DCs lose podosomes. The high correlation between high fascin1 expression and podosome loss may point to a
specialized DC subset or maturation state with high fascin1 expression.
Forced expression of fascin1 results in podosome loss
The above correlation has prompted us to test whether very high
expression of fascin1 in mature DCs is responsible for podosome
loss. To this end, we forced expression of GFP fascin1 in fascin1deficient DCs and counterstained them with the anti-vinculin Ab.
As a control, GFP alone was transfected in a similar way. As Fig.

2Dd–f shows, the introduction of GFP fascin1 resulted in podosome loss in most DCs. In contrast, podosomes remained assembled in fascin1 KO DCs expressing control GFP (Fig. 2Da–c).
Measurements of podosomes in transfected cells (Fig. 2E)
revealed that most (76%) of DCs expressing GFP fascin1 (n =
113) exhibited four or fewer podosomes, whereas only 28% of
DCs expressing control GFP (n = 45) displayed fewer than four
podosomes. These results suggest that high levels of fascin1 in
mature DCs are responsible for podosome loss in mature DCs.
Actin bundling by fascin1 is critical for podosome loss
We next examined whether podosome loss depends on the actinbundling activity of fascin1. Actin-bundling activity of fascin1

Downloaded from www.jimmunol.org on February 17, 2011

FIGURE 3. Fascin1 is critical for membrane dynamics. A–C, Time-lapse, phase-contrast microscopy was performed with wild-type (A) and fascin1-null
(B, C) DCs that had been plated on glass coverslips. B, Shows a fascin1-null DC with a spread shape, the dominant phenotype; C, shows a cell with
a rounded shape, a less common phenotype. Numbers are in seconds. Scale bar, 5 mm. D–F, Kymographs generated from the white one-pixel lines at time
0 in A–C, respectively. Dashed lines in D–F indicate the boundary of the membrane protrusions. G and H, Box plot analyses of protrusion (G) and retraction
(H) rates calculated from kymographs. The bottom and top of each box indicate the first and third quartiles, respectively, and dots indicate outliers. ****p ,
0.0001. I and J, Phase-contrast, time-lapse images of fascin1-null mature DCs exogenously expressing GFP (I) or GFP fascin1 (J). The last images show
fluorescent images at the end (20 min) of imaging to confirm GFP expression. Numbers are in seconds. Scale bar, 5 mm. K and L, Kymographs of GFP (K)-,
and GFP fascin1 (L)-expressing DCs generated from the time-lapse images in I and J, respectively. M and N, Box plot analyses of protrusion (M) and
retraction (N) rates of fascin1-null DCs exogenously expressing GFP or GFP fascin1.
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is largely downregulated by phosphorylation at Ser39 (41, 42)
because phosphorylation at Ser39 disrupts one of the two actin
binding sites of fascin1. We thus expressed unphosphorylatable
(A-fascin1, replacing Ser39 with Ala) and phosphomimetic (Dfascin1, replacing Ser39 with Asp) mutants in fascin1-null DCs.
As shown in Fig. 2Dg–l, A-fascin1 was much more effective than
D-fascin1 at inducing podosome loss. Indeed, quantitative data
(Fig. 2E) revealed that A-fascin1 (n = 102) was slightly more
effective in inducing podosome loss than wild-type fascin1 (Wfascin1), increasing the fraction of DCs without podosomes from
76 6 8 to 85 6 6% (p = 0.006). In contrast, D-fascin (n = 138)
was much less effective than wild-type fascin, resulting in only
42 6 8% of the DCs displaying fewer than four podosomes (p ,
0.0001). These results indicate that the actin-bundling activity of
fascin1 is important for podosome disassembly, and suggest that
phosphorylation of fascin1 could contribute to the regulation of
podosome assembly.
Fascin1 is associated with the actin structure of podosomes
To explore how high fascin1 expression leads to podosome disassembly, we examined whether fascin1 binds to F-actin within
podosomes. Because high expression of fascin1 in wild-type DCs
makes it difficult to determine possible localization of fascin1 at

FIGURE 5. Morphological characterization of wild-type and fascin1null DCs. A, Scanning electron micrographs of wild-type (a) and fascin1deficient (b) mature DCs. Scale bars, 10 mm. B, Orthogonal views of wildtype (a) and fascin1-deficient (b) CD86high DCs. Mature DCs were double
stained with phalloidin and anti-CD86 Ab. Only phalloidin staining is
shown here. The xy images are on the ventral surface. Both xz and yz
images are shown with the top and bottom of cells indicated by dashed
lines. Scale bars, 5 mm. C–E, Box blot analyses of thickness (C), area (D),
and circularity (E) of wild-type and fascin1-deficient DCs. Thickness was
determined without (w/o cfg) or with (w. cfg) cytospin.

podosomes in these cells, we searched for a hematopoietic cell line
that expresses a low level of fascin1 and, at the same time, has
podosome structures. We found that in contrast to primary macrophages, THP-1 cells (human monocytic leukemia cells) express
a low level of fascin1, yet assemble podosomes when differentiated
into macrophages by addition of phorbol ester (33). Double labeling of THP-1 cells with anti-fascin1 and anti–a-actinin Abs
(Fig. 6A) clearly revealed colocalization of fascin1 (green) and
a-actinin (red) at podosomes (arrowheads), with fascin1 being
slightly inside the a-actinin ring structure.
The level of fascin1 in THP-1 cells is ∼10 times lower than that of
fascin1high mature DCs. We thus asked whether an increase in
fascin1 concentration to the level observed with DCs could result in
podosome disassembly in THP-1 cells. As Fig. 6B shows, microinjection of GFP fascin1 induced podosome disassembly (Fig. 6Bc,
6Bd) in most (89%, 50 of 56 injected cells) THP-1 cells within 1 h
(see Fig. 6C for quantitative data). Concomitantly, fascin1-injected
cells frequently became rounded and detached from the substrate
if incubated for a longer time. In contrast, most (66%, 38 of 58
injected cells) of control cells injected with FITC-labeled BSA
retained podosomes (Fig. 6Ba, 6Bb), the percentage of which is
statistically similar to that of uninjected cells (72%, see Fig. 6C).
These results indicate that whereas fascin1 at a low concentration
can bind to actin structure of the podosomes, high fascin1 expression as observed in DCs can cause podosome disassembly.
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FIGURE 4. Fascin1 is critical for chemotaxis and Langerhans cell
migration into draining lymph nodes. A, In vitro chemotaxis toward
the chemokine CCL19, measured with a modified Boyden chamber
(p = 0.0095). B, Immunofluorescence imaging of Langerhans cells in ear
epidermal sheets from wild-type (a, c) and fascin1-null (b, d) mice without
(control; a, b) and with FITC painting (+allergen; c, d). Langerhans cells
(indicated by arrowheads) were labeled with the MHC-II Ab. Representative images from four independent experiments. C, Box plot analyses of
Langerhans cell distribution without or with allergen treatment. NS, no
statistical significance; *p , 0.05, **p , 0.01, ***p , 0.001, ****p ,
0.0001. D, Box plot analysis of FITC-bearing DCs migrated into draining
lymph nodes. p = 0.0059.
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High fascin1 expression is likely to cause the disassembly of
podosomes in mature DCs

Discussion
We have demonstrated that fascin1 plays a critical role in the
alterations in motility, morphology, and adhesion associated with
DC maturation. Fascin1-null DCs, when fully matured, are more
spread, show fewer and less dynamic membrane protrusions, and
retain podosomes. Importantly, fascin1-null DCs show reduced
directed migration both in vitro and in vivo.
Fascin1 is critical for dynamic dorsal ruffling
How does fascin1 enhance the dynamics of membrane protrusions?
We found that fascin1 is colocalized with F-actin at the cortex
of veil-like protrusions (Fig. 1D). Judging from its actin bundling
and cross-linking activity, fascin1 is likely to form a meshwork
of actin filaments at the cortex, which would give the cell cortical
rigidity. Recent studies have shown that the actin cross-linking
activity of fascin1 is extremely dynamic (29, 43, 44), and suggested that this dynamic cross-linking is required for vigorous
movements of filopodia while at the same time maintaining sufficient rigidity for filopodial protrusions (43). A similar mechanism is likely to work for veil-like protrusions of mature DCs. As
the DC cortex protrudes and retracts, fascin1 would be able to
quickly reorganize the actin meshwork, providing both the rigidity
and the flexibility needed to support dynamic membrane protrusions. Such dynamics are likely to be critical for DC migration
through tissues and extracellular matrix to reach the lymph nodes.
In keeping with this idea, we found that Langerhans cells from
fascin1 KO mice show reduced emigration into draining lymph
nodes (Fig. 4B–D).

Loss of podosomes may be critical for migration of mature DCs
Podosomes appear to profoundly alter migration patterns of DCs,
at least in vitro. It has been reported that mature DCs without
podosomes display high-speed migration with low adhesion to the
substrate when compared with immature DCs with podosomes
(10). Such high-speed migration with reduced adhesion would be
advantageous for mature DCs to travel to a lymph node as quickly
as possible for efficient presentation of Ags to naive T cells. In
contrast, immature DCs need to move around the peripheral tissues to constantly sample foreign and host Ags. Such movement
may require an adhesion structure like podosomes for attachment
to the extracellular matrix (10, 13, 14, 54, 55). It is worth noting
that other primary hematopoietic cells like macrophages have
prominent podosomes, whereas no fascin1 expression was detected. These cells may need podosomes as adhesion structures so
that they can move around the peripheral tissues as a sentinel
against external pathogens.
The loss of podosomes might also be critical for the assembly
of an immunological synapse. Geyeregger et al. (56) have shown
that agonists of liver X receptors (LXRs) blocked fascin1 expression in human DCs and, at the same time, inhibited the assembly
of the immunological synapse. Importantly, overexpression of fascin1 in LXR agonist-treated DCs restored immunological synapseassembly (56). We have found that LXR agonists block
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FIGURE 6. Fascin1 is localized to podosomes in THP-1 cells, and
microinjection of fascin1 induces podosome disassembly. A, Colocalization of fascin1 and a-actinin at podosomes. THP-1 cells differentiated with
2-O-tetradecanoylphorbol-13-acetate were labeled with anti-fascin1 (b, e;
green) and anti–a-actinin (red; a, d) Abs. c and f, Merged images. Images
in d–f show enlargements of the boxed areas in a–c. Arrowheads, podosomes. B, Disassembly of podosomes by microinjection of fascin1. THP-1
cells were microinjected with FITC-labeled BSA (a) or GFP fascin1 (c)
and counterstained with phalloidin (b, d). Arrows indicate injected cells,
whereas arrowheads indicate podosomes. C, Percentage of cells with
podosome arrays of uninjected cells (green), or after microinjection of
fascin1 (red) or FITC BSA (blue). Representative data from three independent experiments are shown. Approximately 20 injected cells for
each condition were counted for each set of experiments.

We found that fascin1 expression is closely correlated with the loss
of podosomes in mature DCs. Importantly, forced expression of
fascin1 in fascin1-null DCs resulted in podosome disassembly (Fig.
2). Two recent studies, however, have shown that fascin1 appears
to favor assembly of podosomes, as well as invadopodia, structures closely related to podosomes (45, 46). In platelet-derived
growth factor-treated smooth muscle cells, fascin1 depletion has
been reported to suppress podosome assembly (45). Likewise,
fascin1 has been shown to stabilize F-actin in invadopodia in
melanoma cells (46). We speculate that these apparently contradictory functions of fascin1 may be explained by the difference in
fascin1 expression levels between mature DCs and other cell
types. Mature DCs express fascin1 one order in magnitude higher
than do other cells. In support of this notion, we demonstrated that
podosome assembly could be controlled by altering fascin1 levels in
THP-1 cells: whereas endogenous fascin1 is present at a low level in
THP-1 cells and localized to podosomes, microinjection of a large
amount of fascin1 caused disassembly of podosomes (Fig. 6B, 6C).
An important question is how high levels of fascin1 could cause
podosome disassembly in mature DCs. Fascin1 at a low level binds
to actin structure of podosomes (Fig. 6A), indicating that fascin1
and other actin-binding proteins can simultaneously bind to actin
filaments. However, very high levels of fascin1 would saturate
actin filaments [fascin1 can bind to actin at a molar ratio of 1
fascin1 to 4 actin molecules (47)], which would compete with
other proteins for actin binding (48). Such competition would
result in dissociation of an actin-binding protein(s) that is critical
for the organization of podosomes, leading to disassembly of
podosomes. Indeed, Park et al. (49) have shown that fascin1
debranches Arp2/3 complex-mediated branched filaments, transforming the dendritic filament assembly into actin bundles in vitro.
Because Arp2/3 complex is an essential component of podosomes
(50–53), debranching of Arp2/3-mediated dendritic filaments could
block de novo synthesis and/or maintenance of podosomes. This
idea is consistent with the result that A-fascin1 is much more effective in podosome disassembly than is D-fascin1 because Dfascin1 shows much weaker actin-bundling activity (Fig. 2).
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podosome disassembly in mature, wild-type DCs (S. Yamashiro,
unpublished results), again supporting our notion that the loss of
fascin is highly correlated with sustained podosome assembly.
Perhaps the disassembly of podosomes may facilitate the assembly
of an immunological synapse because these two structures share
molecular constituents (57).
In conclusion, we have demonstrated that fascin1 plays a critical
role in chemotactic migration of DCs. Manipulation of fascin1
expression may thus be effective in enhancing DC-based immune
therapy. For example, whereas tumor Ag-loaded DCs have been
used as cancer vaccines, only a tiny fraction (1%) of DCs s.c.
injected is able to migrate into lymph nodes of cancer patients (58).
It might be possible to increase the efficiency of DC migration by
selecting DCs with high fascin1 expression and/or by exogenously
increasing fascin1 expression.
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